| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 6 buys and 11 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.69M | - | |
| VP | 242.9K | $3.40M | - | |
| Dir | 110.4K | $1.55M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2019 | Stafford John S III | 10% Owner | Buy | 12,641 | $29.87 | $377,586.67 | +0.2% | |
| May 2, 2019 | Stafford John S III | 10% Owner | Buy | 14,611 | $29.87 | $436,407.19 | +0.3% | |
| Mar 25, 2019 | Stafford John S III | 10% Owner | Buy | 5,500 | $29.84 | $164,115.00 | - | |
| Mar 18, 2019 | Stafford John S III | 10% Owner | Buy | 39,400 | $29.04 | $1,144,356.00 | +0.4% | |
| Sep 17, 2018 | Foster Paul A | Chief Medical Officer | Sale+OE | 40,000 | $46.03 | $1,841,208.00 | -89.0% | |
| Sep 14, 2018 | Stafford John S III | 10% Owner | Sell | 1,000 | $48.05 | $48,054.00 | - | |
| Aug 17, 2018 | Foster Paul A | Chief Medical Officer | Sale+OE | 3,659 | $40.10 | $146,725.90 | -42.5% | |
| Aug 16, 2018 | Foster Paul A | Chief Medical Officer | Sale+OE | 36,341 | $41.10 | $1,493,709.63 | -71.0% | |
| Aug 13, 2018 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 50,000 | $40.16 | $2,008,117.12 | -62.8% | |
| Aug 10, 2018 | Desjarlais John R76 | Sr. V.p., Research &CSO | Sale+OE | 35,000 | $40.36 | $1,412,721.13 | -15.5% |